Navigation Links
New cancer drug test promises safer and more effective clinical trials
Date:9/23/2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...erman . , In the current online issue of the... Eyerich and Dr. Kilian Eyerich together with thei...tuto Dermopatico dell,Immacolata in Rome, present ...lestone on the way to developing new treatment met...sis and allergic reactions and potentially also al...
(Date:11/20/2009)... researchers report that a class of heart medicati...rmful, effect on the heart, depending on their mol...he journal Circulation Research , found that beta...eptors on the heart muscle offer the most benefit ...the beta-receptors can actually undermine the stru...
(Date:11/19/2009)...re revealing the genetic instructions inside corn,..., has one of the most complex sequences of DNA eve...enomicist David Schwartz, who was one of more than...e . , "The maize genome is a true maze full of ... would-be sequencers for years," says Schwartz. ,...
Breaking Biology News(10 mins):Discovery of new type of immune cells regulating inflammation in chronic diseases 2Carvedilol shown to have unique characteristics among beta blockers 2Sweet corn story begins in UW-Madison lab 2Sweet corn story begins in UW-Madison lab 3Healthcare Trust of America Inc Executes Agreement to Acquire a 108 500 SF Medical Office Building Located in Spartanburg South Carolina 61272 1Healthcare Trust of America Inc Executes Agreement to Acquire a 108 500 SF Medical Office Building Located in Spartanburg South Carolina 61272 2AvidBiotics Corp Granted Key U S and European Patents on Unique Protein Modification Platform 14820 1AvidBiotics Corp Granted Key U S and European Patents on Unique Protein Modification Platform 14820 2Misonix Announces New Distribution Agreement for Saudi Arabia and Other Middle Eastern Countries 6233 1Misonix Announces New Distribution Agreement for Saudi Arabia and Other Middle Eastern Countries 6233 2Misonix Announces New Distribution Agreement for Saudi Arabia and Other Middle Eastern Countries 6233 3
...ns in the oceanbrought on as a direct result of ri...spell trouble for the earliest stages of marine li...sue of Current Biology , a publication of Cell Pr... 2100 could slash the fertilization success of sea...ws. , " If other marine species respond similarly...
... researcher and his students have developed a nano...tronger and could result in more fuel-efficient ai...nd sports equipment. , The material xGnP Exfolia...n the development of new and expanded applications...ries, said Lawrence Drzal, University Distinguishe...
...rsity of Washington scientists has found that seve...working and living around monkeys have been infect...that, to date, has not been shown to cause human d...ia, where interaction between people and monkeys i...ting for future primate-to-human viral transmissio...
Other Biology News:More acidic ocean could spell trouble for marine life's earliest stages 2'Small' research at MSU leads to advances in energy, electronics 2Simian foamy virus found in several people living and working with monkeys in Asia 2Simian foamy virus found in several people living and working with monkeys in Asia 3
(Date:11/20/2009)...ovember 20 Karolinska Development ...nd (EIF) has entered into a,co-investment agreemen...,managed by Karolinska Development and used to inv...maceutical and medical technology companies. EIF,h...ent fund. The agreement,represents EIF,s largest s...
(Date:11/20/2009)...ER TOLEDO recently announced that a free webinar, ...ng At-Line Particle Characterization”, will ..., the application of in situ particle characteriza...ptimize a series of roller compaction runs while v...ction forces. , (PRWEB) N...
(Date:11/19/2009)...e able to charge their cell phones and other perso...t discovery made by UC San Diego engineers could l...could do just this. , In recent research, publi...ru, a professor in the UCSD Department of Mechanic...student Mark Hoefer, have found that artificially ...
(Date:11/19/2009)...Newswire-FirstCall/ -- Omeros Corporation (Nasdaq:...ts for the third quarter ended September 30, 2009....eros reported a net loss of $3.9 million, or $1.34...ion, or $2.54 per share, for the same period in 20...the Company reported a net loss of $15.5 million, ...
Breaking Biology Technology:Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 3Roller Compaction Process Optimization Using At-Line Particle Characterization 2Nanotube defects equal better energy and storage systems 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8
...al and Organic,Cosmetic* products are now identifi...irst 100 products have already been certified as o...es orientation for consumers and manufacturers,ali... Natural and Organic,Cosmetics. It is internationa...uarantees independent certification based on publi...
... (Nasdaq: ITMN ) announced today that it will re...results on Thursday, February 26, 2009 at 4:00 p.m...t will be hosted by InterMune at 4:30 p.m. Eastern...conference, dial 888-799-0528 (U.S.) or 973-200-33...ccess the webcast, please log on to the company,s ...
...nexa(R) net revenue - , , - Company retires more ... , - Ranexa prescriptions for first week in Februa...TO, Calif., Feb. 20 CV Therapeutics, Inc. (Nasdaq...e fourth quarter and full year ended December 31, ...he company reported a net loss of $98.5 million, o...
Other Biology Technology:NaTrue-Label: The First 100 Products are Certified 2InterMune to Release Fourth Quarter, Full Year 2008 Financial Results on February 26 2CV Therapeutics Reports 2008 Fourth Quarter and Full Year Financial Results 2CV Therapeutics Reports 2008 Fourth Quarter and Full Year Financial Results 3CV Therapeutics Reports 2008 Fourth Quarter and Full Year Financial Results 4CV Therapeutics Reports 2008 Fourth Quarter and Full Year Financial Results 5CV Therapeutics Reports 2008 Fourth Quarter and Full Year Financial Results 6CV Therapeutics Reports 2008 Fourth Quarter and Full Year Financial Results 7CV Therapeutics Reports 2008 Fourth Quarter and Full Year Financial Results 8CV Therapeutics Reports 2008 Fourth Quarter and Full Year Financial Results 9
Human / Mouse / Rat Chk1 Kinase, active ELISA development Kit, DuoSet, IC (Intracellular) from R&D Systems
Bovine Serum Albumin Peroxidase Stabilizer Solution from BioFX Laboratories, Inc.
Rabbit Anti-Human OLFM1 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
...s an agarose-digesting enzyme isolated from Pseudo...bohydrate bonds in agarose producing carbohydrate ...rbohydrate molecules will not interfere with subse...enzyme can be used for restriction endonuclease di...
Biology Products: